GlassScriptPhysician profile
Misti M Bartell
NPI 1932210721
$2,212.50
in general payments reported to CMS, 2019-2025
30 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $64.66 · 2021: $414 · 2022: $606 · 2023: $550 · 2024: $148 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $526.98 | 2020-2025 | Lo Loestrin Fe, Liletta, Ubrelvy |
| Coopersurgical, INC. | $265.97 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $224.63 | 2020-2024 | Novasure, Acessa Provu System |
| Astellas Pharma US INC | $206.96 | 2023-2025 | Veozah |
| Organon LLC | $128.09 | 2021-2023 | Nexplanon |
| Myovant Sciences INC. | $116.62 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $92.30 | 2021-2025 | |
| Pfizer INC. | $56.23 | 2021-2022 | |
| Lupin INC. | $45.56 | 2019 | |
| Inspire Medical Systems, INC. | $42.27 | 2023 | Inspire |
| Novo Nordisk INC | $38.50 | 2022-2023 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $35.69 | 2022-2025 | |
| Therapeuticsmd, INC. | $32.95 | 2019 | |
| Millicent US INC | $31.43 | 2025 | Intrarosa, Femlyv, Femring |
| Merck Sharp & Dohme LLC | $31.30 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $30.39 | 2021-2022 | |
| Allergan, INC. | $30.35 | 2019 | |
| Ethicon US, LLC | $29.87 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $28.68 | 2023 | Myfembree |
| Dexcom, INC. | $28.14 | 2023 | Dexcom G6 Transmitter |
| Aspira Women'S Health INC | $23.89 | 2024 | Ova1 |
| Daiichi Sankyo INC. | $23.44 | 2021 | |
| Hologic INC | $20.90 | 2021 | |
| Gynesonics, INC. | $20.84 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Acessa Health INC. | $20.28 | 2019 | |
| Medtronic, INC. | $18.21 | 2022 | |
| Evofem Biosciences, INC. | $15.90 | 2022 | |
| Optumhealth Care Solutions, LLC | $15.83 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Minerva Surgical, INC | $15.67 | 2019 | |
| Exeltis, USA INC. | $14.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misti Bartell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.